Skip to main content
All lobbying filings

TIBER CREEK GROUP

Lobbying for CIGNA CORPORATION AND SUBSIDIARIES · Employee benefits company.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income · posted Jul 19, 2026

Official filing document

 Bills named in this filing 4
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S 4784
    National Defense Authorization Act for Fiscal Year 2027
  • HR 5582
    Patients Deserve Price Tags Act
  • S 2355
    Patients Deserve Price Tags Act
 Lobbying activity 4
Health Issues

Issues related to pharmacy and prescription drug pricing; Issues relating to implementation of the No Surprises Act (PL 116-260); Issues related to price transparency.

Defense

Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.

Pharmacy

Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.

Medicare/Medicaid

Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem